Table 1 Baseline characteristics of included patients
Low HDL-C (< 1.04 mmol/L) | High HDL-C (≥ 1.04 mmol/L) | p value | |
|---|---|---|---|
Male, n(%) | 44 (80%) | 50 (66%) | 0.513 |
Age(year) | 63.69 ± 11 | 63.03 ± 9.58 | 0.71 |
Hypertension, n(%) | 33 (58%) | 39 (51%) | 0.419 |
Diabetes, n(%) | 19 (35%) | 18 (24%) | 0.244 |
Smoking, n(%) | 17 (31%) | 22 (29%) | 0.961 |
Gout, n(%) | 2 (4%) | 2 (3%) | 0.56 |
LDL-C (mmol/L) | 1.93 ± 0.79 | 2.67 ± 1.08 | 0.000 |
TC (mmol/L) | 3.45 ± 0.87 | 4.85 ± 1.36 | 0.000 |
TG (mmol/L) | 1.27 ± 0.48 | 1.79 ± 1.52 | 0.007 |
sPLA2 IIA (pg/mL) | 5836.92 (3797.444–9198.456) | 7477.828(5291.296–11,965.632) | 0.004 |
Statin treatment, n(%) | 32 (58%) | 39 (51%) | 0.548 |
hsCTNI level (ng/mL) | 0.005 (0.002–0.011) | 0.003 (0.001–0.009) | 0.181 |
Unstable angina, n(%) | 24 (44%) | 21 (28%) | 0.086 |
History of stent implantation, n(%) | 10 (18%) | 12 (19%) | 0.901 |